Clinical Trial Update: Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease [Phase 2]

View source ↗

Summary

Biocad is conducting a Phase 2 clinical study to assess the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of BCD-261 in subjects with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• BCD-261

Snippet

Sponsor: Biocad | Conditions: Crohn's Disease (CD) | Phase 2 | Status: RECRUITING